share_log

Biogen | 8-K: Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024

SEC announcement ·  Feb 13 07:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more